Select Location
We need your delivery location to continue browsing
Prescription Required
MSN Laboratories
7 Tablet
Eltrombopag Olamine
Keep in cold place
Delivering To:
Overview
Rebopag 25mg Tablet belongs to the anticoagulant drug category. These medicines primarily treat patients diagnosed with primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. This tablet is also used in adults to treat low blood counts caused by severe aplastic anemia. Hepatitis is a liver inflammation caused by virus infection and non-infectious agents. When diagnosed in advanced stages, only the symptoms of the disease can be reduced. Rebopag Tablet is not recommended for patients under age 18.
Hepatitis C, Hepatitis Medicines, Low Red Platelet Count
Rebopag 25mg Tablet is a prescription-based medicine used in the treatment of primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. This tablet is also used in adults to treat low blood counts caused by severe aplastic anemia. The active ingredient of the Rebopag is Eltrombopag which belongs to the drug class of thrombopoietin (TPO) receptor agonist. It is taken orally with or without food as per doctor's advice. Rebopag Tablet works by stimulating the formation of new platelets in the blood. The required dosage and duration of the medicine is decided by the doctor. This depends on the disease being treated and the stage of the disease. The doctor will check medical history, age, health condition, and body's response to the treatment before prescribing this medicine. Taking it in the wrong way or overdosing can cause severe side effects. It may take weeks for patients to notice the benefits of the medicine. So do not stop taking this tablet until your doctor says to do so.
The human body shows undesired symptoms after taking Rebopag 25mg Tablet. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Rebopag Tablet are mentioned below:
Cold
Fever
Hair loss
Diarrhea
Back pain
Joint pain
Headache
Muscle pain
Loss of appetite
Abdominal pain
Nausea & Vomiting
Urinary tract infection
Mouth and throat pain
Swelling in feet or hands
Increased level of liver enzyme
Upper respiratory tract infection
Rebopag 25mg Tablet is a prescription-based drug that should be administered orally. It is advised to take this tablet after consulting your healthcare expert.
Rebopag 25mg Tablet is a prescription-based medicine that belongs to category of thrombopoietin (TPO) receptor agonist. This drug stimulates megakaryocytes that are responsible for producing platelets. Through this drug, the number of platelets in the blood increases, which prevents bleeding and bruising.
Alcohol
consult your doctor
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Rebopag 25mg Tablet. It is advised to consult your doctor for further information.
Pregnancy
consult your doctor
Rebopag 25mg Tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition.
Breast Feeding
consult your doctor
Rebopag 25mg Tablet is probably not safe if you're breastfeeding. Kindly consult your doctor.
Driving
unsafe
It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Rebopag 25mg Tablet.
Kidney
safe if prescribed
Share your medical history with your healthcare expert in case of kidney disease before taking Rebopag 25mg Tablet.
Liver
safe if prescribed
Inform your doctor before starting Rebopag 25mg Tablet if you have liver disease to avoid any serious side effects.
It is advised not to miss any scheduled dosage of Rebopag 25mg Tablet. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
It is advised to use effective birth control ways and avoid pregnancy during the treatment with Rebopag Tablet.
A person should avoid smoking while undergoing treatment with Rebopag. Smoking may reduce the effectiveness of medicine.
Monitor your blood sugar & pressure, Kidney & Liver function (KFT & LFT), and Heart function at proper intervals after taking Rebopag Tablet.
Skin becomes extremely sensitive after taking Rebopag. It is advised to cover your skin exposed to direct sun rays and use high SPF sunscreen before going out.
It is advised to avoid taking analgesics/ antacids (medicines used to neutralize the stomach acid) while taking Rebopag Tablet, as it may reduce the effectiveness of the medicine.
Keep your body hydrated as Diarrhea is one of the common side effects experienced after taking an Rebopag Tablet. Consult your doctor if it doesn't stop or if blood appears in your stools.
In case you notice symptoms like blurred vision, difficulty breathing, cough & fever, and diarrhea while taking Rebopag, consult your doctor immediately before these symptoms become severe.
This medicine is given to adults diagnosed with primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. This tablet is also used in adults to treat low blood counts caused by severe aplastic anemia.
Your doctor decides the doses and duration of taking Rebopag 25mg Tablet. It is advised not to crush, chew, or break it, just swallow the whole tablet with water.
The Rebopag may take days to week for working properly. It depends on patients’ medical history, age, health condition, and body's response to the treatment.
The most common side effects of this medicine include Diarrhea, Headache, Tiredness, Mouth sores, Muscle or joint pain, Stomach pain, and difficulty breathing. It is advised to go for regular liver function tests to examine the liver function.
No, there are chances that Rebopag may interact with certain drugs. It is crucial to inform your healthcare expert if you're already taking any medication.
No, this medicine can only help to balance the count of platelets. It is not a permanent cure for thrombocytopenia.